An Asia Pacific Alliance for Rare Diseases

Patient

Volumn 8, Issue 1, 2015, Pages 11-17

  Wong Rieger, Durhane ^a   Claxton, William ^b   Vines, Richard ^c   Padilla, Carmencita ^d   Tsang, Kin Ping ^e   Hickinbotham, Lucy ^f  

^a Canadian Organization for Rare Disorders   (Canada)

^b Mechanobiology Institute Singapore   (Singapore)

^c Rare Cancers Australia TOGA   (Australia)

^d Philippine Society for Orphan Disorders   (Philippines)

^e Retina Hong Kong ^*  (China)

^f Novartis Asia Pacific Pharmaceuticals Pte Ltd   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; DISEASE REGISTRY; EDITORIAL; EUROPEAN MEDICINES AGENCY; FOOD AND DRUG ADMINISTRATION; GENETIC COUNSELING; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; JAPAN; LEARNING; MEDICAL SPECIALIST; NEWBORN SCREENING; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; RARE DISEASE; SOCIAL STIGMA; SOUTH KOREA; SUPPORT GROUP; TAIWAN; TREATMENT OUTCOME; ASIA; HEALTH CARE DELIVERY; INTERNATIONAL COOPERATION; MANAGEMENT; PACIFIC ISLANDS;

ASIA; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNATIONAL COOPERATION; PACIFIC ISLANDS; POLICY MAKING; RARE DISEASES;

EID: 84925539357     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-014-0103-y     Document Type: Editorial

References (28)

1. Mavris M, Le CY. Involvement of patient organisations in research and development of orphan drugs for rare diseases in Europe. Mol Syndromol. 2012;3(5):237–43.
2. Pritchard-Jones K, Pieters R, Reaman GH, Hjorth L, Downie P, Calaminus G, et al. Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries. Lancet Oncol. 2013;14(3):e95–103.
3. Taruscio D, Gentile AE, De SM, Ferrelli RM, de la Posada PM, Hens M, et al. EUROPLAN: a project to support the development of national plans on rare diseases in Europe. Public Health Genomics. 2013;16(6):278–87.
4. Orphanet. About rare diseases. 2014. http://www.orpha.net/consor/cgi-bin/Education_AboutRareDiseases.php?lng=EN. Accessed 10 June 2014.
5. Mazzucato M, Visona Dalla PL, Manea S, Minichiello C, Facchin P. A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region’s rare diseases registry. Orphanet J Rare Dis. 2014;9:37.
6. Franco P. Orphan drugs: the regulatory environment. Drug Discov Today. 2013;18(3–4):163–72.
7. European Organisation for Rare Diseases. Rare diseases: understanding this public health priority. 2005. http://www.eurordis.org/IMG/pdf/princeps_document-EN.pdf. Accessed 10 June 2014.
8. EURORDIS Rare Diseases Europe. Orphan drugs in the United States of America. 2014. http://www.orpha.net/consor/cgi-bin/Education_AboutOrphanDrugs.php?lng=EN&stapage=ST_EDUCATION_EDUCATION_ABOUTORPHANDRUGS_USA. Accessed 13 June 2014.
9. US Government Printing Office Rare Diseases Act. 2002. Accessed 10 June 2014.
10. Commission of the European Communities Rare Diseases: Europe’s challenges. 2008. http://ec.europa.eu/health/ph_threats/non_com/docs/rare_com_en.pdf. Accessed 22 Nov 2014.
11. Harper Government Takes Action to Help Canadians with Rare Diseases. 2012. http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2012/2012-147-eng.php. Accessed 10 June 2014.
12. EURORDIS Rare Diseases Europe. National alliances for rare diseases. 2014. http://www.eurordis.org/content/national-alliances-rare-diseases. Accessed 13 June 2014.
13. Twinning Program. World federation of hemophilia. 2014. http://www.wfh.org/en/page.aspx?pid=872. Accessed 22 Nov 2014.
14. About CNETS. Carcinoid and Neuroendochrine Tumor Society. 2014. http://www.cnets.org/about.htm. Accessed 22 Nov 2014.
15. Taiwan Foundation for Rare Disorders. Rare diseases in Taiwan. 2014. http://www.tfrd.org.tw/english/rare/cont.php?kind_id=16&top1=About%20rare%20diseases&top2=Rare%20Diseases%20in%20Taiwan. Accessed 10 June 2014.
16. Rare Disease and Orphan Drug Act, Taiwan Foundation for Rare Diseases. 2014.
17. Japan Patients Association. About the JPA. 2014. http://www.nanbyo.jp. Accessed 10 June 2014.
18. History Geiser Fundacion. http://www.fundaciongeiser.org/geiser/historia/?lang=en. Accessed 22 Nov 2014.
19. ALIBER (Alianza Iberoamericana de Enfermedades Poco Frecuentes). http://www.aliber.org. Accessed 22 Nov 2014.
20. Soon S, Lopes G, Lim HW, Wong-Rieger D, et al. A call for action to improve access to care and treatment for patients with rare diseases in the Asia-Pacific region. Orphanet J Rare Dis. 2014; 9(1):137.
21. Korean Organization for Rare Disorders. 2014. http://www.kord.or.kr/#. Accessed 10 June 2014.
22. Chinese Organization for Rare Disorders. Chinese Organization for Rare Disorders (CORD). 2014. http://chinadolls.org.cn. Accessed 10 June 2014.
23. Rare Disorders Society (Singapore). 2014. http://www.rdss.org.sg. Accessed 10 June 2014.
24. Malaysian Rare Disorders Society. Malaysian Rare Disorders Society. 2014. http://www.mrds.org.my. Accessed 22 Nov 2014.
25. Philippine Society for Orphan Disorders. Who we are. 2012. http://www.psod.org.ph/about-us/who-we-are/. Accessed 13 June 2014.
26. New Zealand Organisation for Rare Disorders. New Zealand Organisation for Rare Disorders (NZORD). 2013. http://www.nzord.org.nz/. Accessed 10 June 2014.
27. Rare Voices Australia. Rare Voices Australia. 2014. http://www.rarevoices.org.au/. Accessed 10 June 2014.
28. Ride together for better care. Rare Disease Day Thailand. 2014. https://www.facebook.com/rarediseasedaythailand. Accessed 22 Nov 2014.